Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.23.3
Net Loss per Common Share (Tables)
9 Months Ended
Sep. 30, 2023
Net Loss per Common Share  
Schedule of Diluted Weighted Average Shares Outstanding

​

​

​

​

​

​

​

    

​

​

​

Nine Months Ended September 30, 

​

​

2023

    

2022

Warrants to purchase Common Stock

 

127,296

 

268,699

Options to purchase Common Stock

 

34,890

 

54,128

Unvested Restricted Stock

 

1,369,105

 

1,229,750

Unvested Restricted Stock Units

 

152

 

3,407

Total

 

1,531,443

 

1,555,985

​